Inflammopharmacology

Mechanisms of peptic ulcer recurrence: role of inflammation
pp. 291-302(12)
Authors: Watanabe T.; Higuchi K.; Tanigawa T.; Tominaga K.; Fujiwara Y.; Arakawa T.

Prostaglandin EP receptor subtypes and gastric cytoprotection
pp. 303-312(10)
Authors: Takeuchi K.; Hase S.; Takeeda M.; Nakashima M.; Yokota A.

NSAID-induced small intestinal damage: role of COX inhibition
pp. 313-325(13)
Authors: Tanaka A.; Matsumoto M.; Nakagiri A.; Kato S.; Takeuchi K.

Duodenal defence mechanisms: role of mucosal bicarbonate secretion
pp. 327-332(6)
Authors: Flemström G.; Sjöblom M.

Role of small GTP-binding proteins and cytoskeleton in gastric acid secretion
pp. 333-341(9)
Authors: Matsukawa J.; Tashiro K.; Nagao T.; Urushidani T.

Multiple roles for protease-activated receptor-2 in gastric mucosa
pp. 343-349(7)
Author: Kawabata A.

CCK₂ receptors are necessary for the differentiation and proliferation of ECL cells in mouse and rat stomach
pp. 351-364(14)
Authors: Chen D.; Håkanson R.; Rehfeld J.F.; Zhao C-M.

A new role of heparin: A polysaccharide for gastrointestinal diseases
pp. 365-374(10)
Authors: Ye Y.N.; Li Y.; Koo M.W.L.; Cho C.H.

Experimental antral ulcer and several protective drugs
pp. 375-384(10)
Author: Hung C.R.

Acetic acid ulcers: a new method for producing solitary chronic ulcers in rat stomachs by intraluminal application of acetic acid solution
pp. 385-389(5)
Authors: Amagase K.; Okabe S.

Therapeutic effect of rebamipide in a modified acetic acid-induced buccal mucosal ulcer model
pp. 391-399(9)
Authors: Ishiyama H.; Kawai K.; Azuma A.; Nagano C.

Role of endogenous glucocorticoids in the healing of gastric erosions and chronic gastric ulcers in rats
pp. 401-412(12)
Authors: Filaretova L.; Bagaevaand T.; Podvigina T.

Selective cyclooxygenase-2 inhibitor induces gastric mucosal damage in adrenalectomized rats
pp. 413-422(10)
Authors: Filaretova L.; Tanaka A.; Komoike Y.; Takeuchi K.

Helicobacter pylori attenuates the delay in ulcer healing induced by aspirin and selective COX-2 inhibitor
pp. 423-433(11)
Authors: Brzozowski T.; Konturek P.C.; Sliwowski Z.; Konturek S.; Bielanski W.; Pajdo R.; Drozdowicz D.; Hahn E.

Induction of intestinal damage by rofecoxib, the selective COX-2 inhibitor, under inhibition of nitric oxide production in rats
pp. 435-447(13)
Authors: Ohno R.; Miyazawa T.; Hayashi Y.; Kanatsu K.; Tanaka A.; Takeuchi K.

Involvement of nitric oxide (NO) in the mechanism of gastric preconditioning induced by short ischemia
pp. 449-460(12)
Authors: Brzozowski T.; Konturek P.C.; Pajdo R.; Drozdowicz D.; Pawlik M.; Ptak A.; Konturek S.J.; Hahn E.G.

Nitrergic modulation of acetylcholine release in the enteric nervous system: differences between guinea-pig and man
pp. 461-469(9)
Authors: Kilbinger H.; Farrokh A.; Hohenfellner M.; Mang C.F.

Ammonia and gastric acid secretion: a key to understanding activity and regulation of the H⁺,K⁺-ATPase
pp. 471-481(11)
Author: Hagen S.J.

High quality of ulcer healing in rats by lafutidine, a new-type histamine H₂-receptor antagonist: involvement of capsaicin-sensitive sensory neurons
pp. 483-493(11)
Authors: Ajioka H.; Matsuura N.; Miyake H.

Autoradiographic and confocal laser microscopic observation show lafutidine binds to CGRP-immunoreactive nerves as well as gastric parietal cells
pp. 495-503(9)
Authors: Nakamura M.; Akiba Y.; Matsui H.; Ishii H.; Tsuchimoto K.

Effect of lafutidine on CGRP release from cultured rat dorsal root ganglion cells
pp. 505-514(10)
Authors: Nishihara K.; Nakano M.; Nozawa Y.; Ajioka H.; Kanda A.; Matsuura N.; Miyake H.

Amelioration of caerulein-induced pancreatitis by restraint stress in the rat
pp. 515-524(10)
Authors: Abe M.; Kato S.; Okayama M.; Mitsufuji S.; Takeuchi K.

Advances in Gastrointestinal Pharmacology
pp. 525-577(53)

Announcement
pp. 579-579(1)